Methicillin-Resistant Staphylococcus Aureus Bacteremia: Epidemiology, Clinical Characteristics, Risk Factors, and Outcomes in a Tertiary Care Center in Riyadh, Saudi Arabia

被引:7
|
作者
Alhunaif, Sarah A. [1 ]
Almansour, Sarah [2 ]
Almutairi, Raghad [1 ]
Alshammari, Sara [1 ]
Alkhonain, Lamia [1 ]
Alalwan, Bassam [3 ]
Aljohani, Sameera [3 ]
Alsaedy, Abdulrahman [2 ]
Bosaeed, Mohammad [2 ]
Alothman, Adel [4 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia
[2] King Abdul Aziz Med City, Natl Guards Hlth Affairs, Div Infect Dis, Dept Internal Med, Riyadh, Saudi Arabia
[3] King Abdul Aziz Med City, Natl Guards Hlth Affairs, Dept Pathol & Lab Med, Riyadh, Saudi Arabia
[4] King Abdullah Int Med Res Ctr, Dept Infect Dis, Riyadh, Saudi Arabia
关键词
methicillin resistant staphylococcus aureus (mrsa); incidence; risk factors; mortality; bacteremia; methicillin resistant staphylococcus aureus bacteremia; LENGTH-OF-STAY; MRSA ACQUISITION; PREVALENCE; MANAGEMENT; INFECTION; ADMISSION;
D O I
10.7759/cureus.14934
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Methicillin-resistant Staphylococcus aureus (MRSA) has become increasingly common in hospitals worldwide. In an era of pandemics, it is important to understand all types of infectious diseases in order to control its outcome and reduce mortality rates related to it. This study aims to identify the epidemiology of MRSA bloodstream infection, risk factors, and mortality in King Abdulaziz Medical City in Riyadh. Methods This is a retrospective chart review study from January 2013 to June 2017. All patients with positive blood culture for MRSA al King Abdulaziz Medical City (KAMC), which is a tertiary care center in Riyadh, Saudi Arabia, were included. Data were extracted from electronic and paper medical records for patients who had a positive blood culture for MRSA. Data collected included demographics, microbiological details, risk factors, and 30-day mortality. Results From 2013 through June 2017, 633 Staphylococcus aureus bacleremia were reported in KAMC, of which 184 (29.1%) were MRSA with a mean age of 60 +/- 19 years. Almost all of our isolates were susceptible to vancomycin, linezolid, and tigecycline. The most common infectious syndrome these patients presented with was an endovascular infection which accounts for 30.4% while 19.9% presented as a case of pneumonia. The mortality within 30 days of collection of the positive blood culture was 20.65%. Male gender (OR = 2.33; 95% CI =1.34-4.05; P-value = 0.003) and patients with history of recent hospital (OR = 2.34; 95% CI = 1.27-4.34; P-value = 0.007) or ICU (OR =1.66; 95% CI =1.09-2.52; P-value = 0.018) admissions were more likely to acquire MRSA. Conclusions The incidence of MRSA bacteremia at King Abdulaziz Medical City is high and increasing in conjunction with incidence rate posing a significantly high rate of mortality. Recent history of hospital admission, ICU admission and males were found to be significantly associated with higher rates of MRSA infection. Some modifiable risk factors that could be used to facilitate the reduction of MRSA acquisition rates is to avoid unnecessary hospital and ICU admissions.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Clinical Features of Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus in a Tertiary Hospital
    Yamada, Koichi
    Yanagihara, Katsunori
    Hara, Yukiko
    Araki, Nobuko
    Harada, Yousuke
    Morinaga, Yoshitomo
    Matsuda, Junichi
    Izumikawa, Koichi
    Seki, Masafurni
    Kakeya, Hiroshi
    Yamamoto, Yoshihiro
    Kohno, Shigeru
    Kamihira, Shimeru
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 224 (01): : 61 - 67
  • [12] Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia in Gaborone, Botswana
    Wood, Sarah M.
    Shah, Samir S.
    Bafana, Margaret
    Ratner, Adam J.
    Meaney, Peter A.
    Malefho, Kolaatamo C. S.
    Steenhoff, Andrew P.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (08): : 782 - 785
  • [13] Methicillin-resistant Staphylococcus aureus metrics for patients in Saudi Arabia
    Nazeer, Asghar
    Al-Tawfiq, Jaffar A.
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2012, 6 (03): : 223 - 233
  • [14] Risk factors associated with methicillin-resistant Staphylococcus aureus in a tertiary-care hospital
    Kyaw, W. M.
    Chow, A.
    Lye, D.
    Thinn, K. K.
    Lee, V.
    Ang, B.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S21 - S21
  • [15] Spectrum of Virulence Factors in Clinical Isolates of Staphylococcus aureus and Prevalence of SCCmec Types in Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Center
    Khodabux, Rhea Michelle J.
    Mariappan, Shanthi
    Sekar, Uma
    JOURNAL OF LABORATORY PHYSICIANS, 2023, 15 (03) : 450 - 461
  • [16] Molecular characterization of methicillin-resistant Staphylococcus aureus recovered from outpatient clinics in Riyadh, Saudi Arabia
    Moussa, Ihab M.
    Shibl, Atef M.
    SAUDI MEDICAL JOURNAL, 2009, 30 (05) : 611 - 617
  • [17] The epidemiology of methicillin-resistant Staphylococcus aureus at a Saudi University Hospital
    Bukharie, HA
    Abdelhadi, MS
    MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2001, 7 (04): : 413 - 416
  • [18] The prevalence of Staphylococcus aureus and methicillin resistant Staphylococcus aureus in milk and dairy products in Riyadh, Saudi Arabia
    Alghizzi, Mashael
    Shami, Ashwag
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (12) : 7098 - 7104
  • [19] Epidemiology and clonality of methicillin-resistant and methicillin-susceptible Staphylococcus aureus causing bacteremia in a tertiary-care hospital in Spain
    Chaves, F
    García-Martínez, J
    de Miguel, S
    Sanz, F
    Otero, JR
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (02): : 150 - 156
  • [20] Analysis of Staphylococcal Toxins and Clinical Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia
    Maeda, Masayuki
    Shoji, Hisashi
    Shirakura, Tetsuro
    Takuma, Takahiro
    Ugajin, Kazuhisa
    Fukuchi, Kunihiko
    Niki, Yoshihito
    Ishino, Keiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (07) : 1195 - 1200